Anti-CD20 CAR-T cells

CD20-targeted chimeric antigen receptor T cells · Beijing Biohealthcare Biotechnology Co.,Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Anti-CD20 CAR-T cells, covering 2016-11-16 to 2018-07-03. Get the full timeline:

Most recent: Clinical Trial Update: The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma [Phase 1]

See pricing